Prophylactic fenoldopam for renal protection? No, thank you, not for me - Not yet at least

Critical Care Medicine

Volumn 33, Issue 11, 2005, Pages 2681-2683

  Kellum, John A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Acute renal failure; Dopamine; Fenoldopam; Intensive care; Sepsis; Serum creatinine

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; FENOLDOPAM; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST;

CLINICAL RESEARCH; CREATININE BLOOD LEVEL; DRUG APPROVAL; DRUG UTILIZATION; EDITORIAL; EVIDENCE BASED MEDICINE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GLOMERULUS FILTRATION RATE; HEART OUTPUT; HUMAN; HYPOTENSION; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY PERFUSION; LENGTH OF STAY; MEDICAL DECISION MAKING; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZATION; RENAL PROTECTION; SAMPLE SIZE; SEPSIS;

EID: 27944444923     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000186743.30595.AA     Document Type: Editorial

References (25)

1. Mulrow CD: Rationale for systematic reviews. In: Systematic Reviews. Chalmers I, Altman DG (Eds). London, BMJ Publishing Group, 1995, pp 1-8
2. Maleck W, Piper S, Koetter K: Use of dopamine in acute renal failure. Crit Care Med 2002; 30:1934-1936
3. Kellum JA, Decker JM: Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 2001; 29:1526-1531
4. Bellomo R, Chapman M, Finfer S, et al: Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Lancet 2000; 356:2139-2143
5. Marik PE: Low-dose dopamine: A systematic review. Intensive Care Med 2002; 28:877-883
6. Debaveye YA, Van den Berghe GH: Is there still a place for dopamine in the modern intensive care unit? Anesth Analg 2004; 98:461-468
7. Friedrich JO, Adhikari N, Herridge MS, et al: Meta-analysis: Low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005; 142:510-524
8. Brower RG, Matthay MA, Morris A, et al: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Me 2000; 342:1301-1308
9. Heyland DK, Cook DJ, Dodek PM: Prevention of ventilator-associated pneumonia: Current practice in Canadian intensive care units. J Crit Care 2002; 17:161-167
10. Morelli A, Ricci Z, Bellomo R et al: Prophylactic fenoldopam for renal protection in sepsis: A randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 2005; 33:2451-2456
11. Cook DJ, Hebert PC, Heyland DK, et al: How to use an article on therapy or prevention: Pneumonia prevention using subglottic secretion drainage. Crit Care Med 1997; 25:1502-1513
12. Guyatt GH, Sackett DL, Cook DJ: Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? JAMA 1994; 271:59-63
13. Hoffmann U, Fischereder M, Kruger B, et al: The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004; 15:407-410
14. Lameire N, Van Biesen W, Vanholder R: Acute renal failure. Lancet 2005; 365:417-430
15. Di Giantomasso D, Morimatsu H, May CN, et al: Intrarenal blood flow distribution in hyperdynamic septic shock: Effect of norepinephrine. Crit Care Med 2003; 31:2509-2513
16. Bellomo R, Kellum JA, Wisniewski SR, et al: Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med 1999; 159:1186-1192
17. Kellum JA, Leblanc M, Venkataraman R: Acute renal failure. Clin Evid 2004; 11:1094-1118
18. Tumlin JA, Finkel KW, Murray PT, et al: Fenoldopam mesylate in early acute tubular necrosis: A randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 2005; 46:26-34
19. Stone GW, McCullough PA, Tumlin JA, et al: Fenoldopam mesylate for the prevention of contrast-induced nephropathy: A randomized controlled trial. JAMA 2003; 290:2284-2291
20. Bove T, Landori G, Calabro MG, et al: Reno-protective action of fenoldopam in high-risk patients undergoing cardiac surgery: A prospective, double-blind, randomized clinical trial. Circulation 2005; 111:3230-3235
21. Van den Berghe G: How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004; 114:1187-1195
22. Metnitz PG, Krenn CG, Steltzer H, et al: Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002; 30:2051-2058
23. Hoste E, Clermont G, Kersten A, et al: Clinical evaluation of the new RIFLE criteria for acute renal failure. Abstr. Crit Care 2004; 8:P81
24. Kellum JA: A drug to prevent renal failure? Lancet 2003; 362:589-590
25. Sward K, Valsson F, Odencrants P, et al: Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial. Crit Care Med 2004; 32:1310-1315